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Cytokines: IL-21 joins the γc-dependent network?
Christian A.J. Voßhenrich and James P. Di Santo
The discovery of the cytokine IL-21 adds another
member to the ever-growing list of small secreted
molecules that have potent effects on lymphoid cells.
Initial characterization of the IL-21 receptor complex
suggests that IL-21 may belong to the cytokine family
whose receptors share the common γ chain, γc.
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Cytokines are essential for the regulation of immune func-
tion, serving as an important means of communication
between various hematopoietic cells and influencing lym-
phocyte development. In recent months, new cytokines
have been discovered faster than their names can be
agreed on. Unfortunately, this has led to confusion in the
literature, as two new cytokines that are clearly distinct
molecular entities were both initially designated inter-
leukin-21 (IL-21). To remedy the situation, the molecule
described by Parrish-Novak et al. [1] has been formally
designated IL-21, while the IL-9-induced factor, IL-TIF
[2] has provisionally been renamed as IL-22 [3]. The iden-
tification of IL-21 and its receptor [1,4] seems to be of par-
ticular significance because these proteins are most related
to the cytokines and receptor chains that use the common
cytokine receptor γ chain, γc (reviewed in [5,6]; Figure 1).
Also, the expression and function of this cytokine and its
receptor suggest that IL-21 is an exciting new player in
lymphoid differentiation that may provide new insights
into outstanding questions regarding the immunological
phenotype caused by γc deficiency. 
The IL-21 receptor was identified as a potential open
reading frame in the human genome encoding a protein
with motifs common to type I cytokine receptors — two
paired cysteine residues, a WSXWS motif (in single-letter
amino acid code) in the extracellular domain and a box 1
motif in the putative intracellular domain. Sequence analy-
sis showed that the IL-21 receptor had significant homol-
ogy to the β chain of the IL-2 receptor, the α chain of the
IL-4 receptor and the IL-9 receptor ([1,4]; our unpublished
observations). The gene encoding the IL-21 receptor
mapped to human chromosome 16p12 with the first exon
situated just 39 kb from the IL-4Ra locus. Although this
mapping suggests that the IL-21 receptor and the IL-4
receptor α chain may have derived from a common ances-
tral gene, Ozaki et al. [4] point out that the genomic organi-
zation of these genes is not highly conserved.
Parrish-Novak et al. [1] went on to generate cell lines
stably expressing the IL-21 receptor and used these cells
to functionally clone the IL-21 ligand. Sequence analysis
of the ligand predicted a four-helix-bundle type I cytokine
with homology to IL-15, IL-4 and IL-2. The IL-21 gene
maps to the same locus as the IL-2 gene on human chro-
mosome 4q26–27, where they are separated by about
180 kb [1]. IL-21 and its receptor therefore share signifi-
cant protein sequence homology with cytokines and
receptors that require the γc chain for functional signaling,
leading to speculation that they may also belong to the γc-
dependent cytokine network (Figure 1).
Using northern blot analysis to analyse RNA expression
levels, the IL-21 receptor was revealed to have a lym-
phoid-restricted pattern of expression with the strongest
signals in the thymus and spleen in both humans and
mice. Using biotinylated IL-21, Parrish-Novak et al. [1]
detected cell-surface IL-21 receptor on human CD23+
peripheral B cells and CD56+ natural killer cells but not
on peripheral CD14+ or CD3+ cells. Ozaki et al. [4] found
that IL-21 receptor mRNA was regulated in an activation-
dependent fashion in T cells. Whether this phenomenon
also applies to B or natural killer cells is not known. It
would be interesting to know whether the activation-
specific expression of the IL-21 receptor in T cells also
occurs more generally in lymphoid precursors or in other
hematopoietic lineages and their precursors.
Unlike its receptor, expression of IL-21 appeared much
more restricted: northern analysis on multiple normal
murine tissues failed to detect any IL-21 mRNA, although
RT-PCR revealed that IL-21 was expressed by activated
(but not resting) peripheral CD4+ T cells [1]. This IL-21
expression pattern parallels that of IL-2; perhaps these
two cytokines are under coordinate control by common
regulatory elements. Moreover, these observations open
up the possibility that IL-21 may be used by T cells to
stimulate effector functions in an autocrine or paracrine
fashion. Considering the structural homology between
IL-21 and IL-15 and their abilities to stimulate natural
killer cells (see below), it would be of interest to know
whether IL-21 (like IL-15) is expressed by stromal cells in
the bone marrow or thymus, where IL-21 receptor expres-
sion is greatest [1,4]. Despite the similarities, the expres-
sion of IL-21 and the IL-21 receptor contrasts markedly
from that of IL-15 and the IL-15 receptor α chain, which
are detected in a diverse range of non-lymphoid tissues
(reviewed in [7]).
Clues to the structural composition of the biologically
active form of cytokine receptors can be gained by exam-
ining the signalling cascade initiated following ligand
binding. Both Parrish-Novak et al. [1] and Ozaki et al. [4]
have examined this issue, using chimeric receptors con-
taining the IL-21 receptor intracellular region coupled to
either the thrombopoietin (Tpo) or erythropoietin (Epo)
receptors, respectively [1,4]. In these experiments, ligand
binding induces homodimerization of the chimeric recep-
tor to initiate signalling; by co-expressing similar γc-con-
taining chimeric receptors, the potential effects of
heterodimerization with γc can be assessed. Unfortunately,
the results obtained were not completely clear-cut: in one
case, IL-21 receptor homodimers appeared capable of
weak signalling in the BaF3 pro-B cell line, but not in the
32D myeloid progenitor cell line or the CTLL2 cytotoxic
T-cell line [4]. The Tpo–IL-21 receptor chimera used by
Parrish-Novak et al. [1] was also functional in BaF3 cells.
To investigate the possible formation of a complex
between the IL-21 receptor and γc, Ozaki et al. [4] found
that the co-expression of an Epo–γc chimera with the
Epo–IL-21 receptor chimera enhanced the response only
in BaF3 cells. Also, Don Foster’s group at ZymoGenetics
has found that γc antibodies can block IL-21-induced pro-
liferation in IL-21 receptor expressing cells (D. Foster,
personal communication). Collectively, the data leave
open a role for γc in IL-21 receptor function, although the
results should be interpreted with caution as transfected
cells represent rather non-physiological systems. 
Cytokine receptors that require the γc chain have been
shown to associate with the Jak1 and Jak3 members of the
Janus tyrosine kinase family and to activate the signal
transducers and activators of transcription Stat3 and Stat5
(reviewed in [8]). Ozaki et al. [4] found that the IL-21
receptor associated with Jak1 in various cell lines and in
human peripheral blood cells. Upon homodimerization of
an IL-21 receptor chimera in transfected cells, Jak1 (but
not Jak2, Jak3 or Tyk2) was phosphorylated and Stat5a
and Stat5b (but not Stat3) were activated [4]. Unfortu-
nately, the effects of the γc chimera were not tested in par-
allel. These results await confirmation using native IL-21
stimulation of murine and human primary lymphocytes. It
is clear that we still have much to learn about the composi-
tion of the native IL-21 receptor complex.
IL-21 was found to have potent effects on all classes of
lymphocytes: B, T and natural killer cells [1]. Curiously,
IL-21 was shown to provide co-stimulation for anti-CD40-
activated B cells, while it inhibited proliferation induced
by anti-IgM antibodies and IL-4. Although competition
for a shared receptor subunit — such as γc — might be
responsible for this observation, such competition cannot
fully explain the result as both IL-21 and IL-4 appear
capable of stimulating B-cell growth. Along these lines, it
would be interesting to see whether IL-21 and IL-4 would
cross-inhibit anti-CD40-mediated B-cell stimulation, or if
IL-21 can act as a positive co-stimulator for anti-IgM-acti-
vated B cells in the absence of IL-4.
With respect to inducing proliferation of peripheral T
cells, IL-21 alone appeared inert, but acted synergistically
with a proliferative signal provided by anti-CD3 antibod-
ies. This may be explained by the fact that quiescent T
cells do not express the IL-21 receptor, but activated T
cells do. In contrast, thymocytes express high levels of the
IL-21 receptor [1,4], but surprisingly IL-21 alone does not
induce their proliferation. One possibility is that anti-CD3
antibody treatment induces the expression of another
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Figure 1
Non-redundant roles for γc-dependent
cytokine signalling. While γc-dependent
cytokines activate shared signalling pathways
and promote similar effects in vitro (reviewed
in [5]), they appear to have unique biological
roles in vivo. The essential roles played by
IL-2, IL-4, IL-7, IL-9 and IL-15 as deduced
from gene ablation studies in mice or natural
mutations in humans are indicated (reviewed
in [6]). The non-redundant roles of IL-21
in vivo remain to be determined. 
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receptor subunit or another cytokine that can synergize
with IL-21. Alternatively, the IL-21 receptor may be
expressed by a subset of thymocytes — such as the imma-
ture CD4+CD8+ cells — and downregulated as the cells
mature. Upon activation with anti-CD3 antibodies, mature
thymocytes would then re-express the IL-21 receptor like
peripheral T cells. Finally, the effect of IL-21 on thymo-
cytes may be more related to differentiation or survival
than induction of proliferation.
One of the most interesting biological activities of IL-21 is
exerted on natural killer cells. IL-21 as a single agent sub-
stantially increased the cytotoxic activity of mature natural
killer cells. This effect appeared independent of prolifera-
tion. An in vitro system of natural killer cell differentiation
from human hematopoietic stem cells has been described
[9,10], in which certain cytokines (including stem cell
factor, Flt3 ligand and IL-15) appear particularly potent in
promoting natural killer cell development. One unusual
aspect of this system is that the CD56+ natural killer cells
generated, while potently cytolytic, lack CD16 expression
compared with the majority of circulating mature natural
killer cells in humans [9]. While IL-21 alone was not
capable of inducing natural killer cell differentiation in
this system, IL-21 synergized with Flt3 ligand and IL-15
to promote more rapid growth of lytic natural killer cells
from CD34+ cells [1]. Interestingly, the resulting natural
killer cells were CD16+. Thus, IL-21 may provide unique
signals for the final maturation of natural killer cells.
The possibility that IL-21 belongs to the γc-dependent
cytokine network might help to explain some discrepan-
cies between the phenotype resulting from γc deficiency
with the phenotype of mice deficient in single or multiple
γc-dependent ligands. The evidence to date suggests that
γc-dependent cytokines do not act in a redundant fashion,
but rather each ligand–receptor system has important
essential roles in immune system differentiation (reviewed
in [6]; Figure 1). For example, IL-4 appears as an essential
factor for immunoglobulin isotype switch to IgG1 and IgE,
IL-7 has a non-redundant role in early lymphoid develop-
ment, while IL-9 is involved in mast and goblet cell differ-
entiation [11–13]. In the absence of any of these
cytokines, there is no obvious compensation by other
members of the γc-dependent network. The unique role
for IL-21 as a γc-dependent cytokine in natural killer cell
differentiation could help to explain why mice deficient in
IL-15 signalling have reduced natural killer cells, while γc-
deficient mice completely lack this lymphoid subset
[14–17]. The essential biological roles of IL-21 in vivo
should be more clearly elucidated through the generation
of mice deficient in this cytokine and its receptor.
The homologies of IL-21 and the IL-21 receptor to known
γc-dependent cytokines and their receptors, the restricted
pattern of IL-21 and IL-21 receptor expression and the
potent activities of IL-21 make it more than just another
cytokine–receptor pair. There are many questions to be
addressed — but no doubt we will soon have some answers.
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